Items where authors include "Nevitt, Sarah Jane"

Article

Walton, Matthew James orcid.org/0000-0003-1932-3689, Deng, Nyanar J, Corbett, Mark Stephen orcid.org/0000-0002-5937-1493 et al. (7 more authors) (2025) Re-anchoring the value of innovative therapies in NICE decision making when comparators are cost-ineffective:A case study of late-onset Pompe disease. PharmacoEconomics. ISSN 1179-2027

Walton, Matthew James orcid.org/0000-0003-1932-3689, Deng, Jasmine, Corbett, Mark Stephen orcid.org/0000-0002-5937-1493 et al. (7 more authors) (2025) The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS. European Journal of Health Economics. ISSN 1618-7601 (In Press)

Corbett, Mark Stephen orcid.org/0000-0002-5937-1493, Umemneku-Chikere, Chinyereugo orcid.org/0000-0003-4114-2227, Nevitt, Sarah Jane orcid.org/0000-0001-9988-2709 et al. (7 more authors) (2025) Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease:A systematic review and network meta-analysis. Orphanet Journal of Rare Diseases. 451. ISSN 1750-1172

Nevitt, Sarah Jane orcid.org/0000-0001-9988-2709, Phillippo, David M., Hodgson, Robert orcid.org/0000-0001-6962-2893 et al. (2 more authors) (2025) Application of Multilevel Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia: an External Assessment Group perspective. PharmacoEconomics. pp. 243-247. ISSN 1179-2027

Flom, Peter, Harron, Katie, Ballesteros, Javier et al. (5 more authors) (2024) Common errors in statistics and methods. BMJ Paediatrics Open. e002755. ISSN 2399-9772